Kelly Zach, MD
Interventional Pain Medicine · Lincoln, NENPI 1871889287
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,451 of the $15,368 with a category attached, or 61.5%. It is spread thinly across 45 manufacturers, the largest accounting for just 22.7%.
Across 432 payments — averaging $35.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$3K
- Spinal Simplicity, LLC$2K
- Vertiflex, Inc.$1K
- AbbVie$1K
- Abbott$1K
- Relievant Medsystems, Inc.$933
- plus $5K from 39 others
What the payments were for
- Travel & lodging$3,13520%
- Food & beverage$9,45162%
- Education$2,78118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$2,015
- HA MINUTEMAN G3-R$1,916
- Intracept$1,464
- Superion ISS$1,180
- Nalu Neurostimulation System$745
- PROCLAIM$161
- Axium INS DRG IPG$152
- Omnia$135
- SUBLOCADE$125
How this compares
Too few interventional pain medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 17 | $3,044 |
| Duloxetine Hcl | 54 | $759 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $601 |
| Gabapentin | 56 | $494 |
| Pregabalin | 21 | $412 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $355 |
| Tizanidine Hcl | 23 | $326 |
| Meloxicam | 27 | $237 |
| Cyclobenzaprine Hcl | 20 | $226 |
| Oxycodone Hcl | 11 | $123 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lincoln
- Clayton DammeLincoln$21K
- Soubrata RaikarFremont$38K
- Pravardhan BirthiGrand Island$19K
- Thomas BrooksElkhorn$13K
- Rafal KrejzaOmaha$13K
- Jery InbarasuOmaha$12K
- Kevin BalterOmaha$11K
- Madhuri AreOmaha$904
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.